In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

A protein called HER3, which is present on the blood–brain barrier, helps the tumour-invading protein cross from the ...

Bypassing the blood-brain barrier (BBB) has been one of the greatest hurdles in the development of treatments for patients living with brain cancer with glioblastomas for a long time now.

A unique protein designed by Cedars-Sinai Cancer investigators can cross the protective blood–brain barrier safely and deliver therapy directly into cancerous tumor cells, a preclinical study shows.

Scientists performed a first-ever clinical test of the therapy avapritinib in pediatric patients with high-grade glioma. They ...

A new therapy offers hope for treating pediatric brain tumors, targeting cancer cells while minimizing side effects for young ...

Lab mice with glioblastoma lived longer with a new combination treatment than with radiation alone—and some even achieved long-term tumor control.

Researchers of a new study have discovered that DSRD patients showed signs of neuroinflammation and blood-brain barrier ...